BNT162b2 Against COVID-19-Associated Emergency Department and Urgent Care Visits Among Children 5-11 Years of Age: A Test Negative Design.
BNT162b2
COVID-19
Kaiser Permanente
SARS-CoV-2
United States
booster
delta
effectiveness
omicron
pediatric
real-world
test-negative
Journal
Journal of the Pediatric Infectious Diseases Society
ISSN: 2048-7207
Titre abrégé: J Pediatric Infect Dis Soc
Pays: England
ID NLM: 101586049
Informations de publication
Date de publication:
18 Apr 2023
18 Apr 2023
Historique:
received:
27
10
2022
accepted:
26
01
2023
medline:
20
4
2023
pubmed:
31
1
2023
entrez:
30
1
2023
Statut:
ppublish
Résumé
In a 1:1 matched test-negative design among 5- to 11-year-olds in the Kaiser Permanente Southern California health system (n = 3984), BNT162b2 effectiveness against the omicron-related emergency department or urgent care encounters was 60% [95%CI: 47-69] <3 months post-dose-two and 28% [8-43] after ≥3 months. A booster improved protection to 77% [53-88].
Identifiants
pubmed: 36715070
pii: 7008779
doi: 10.1093/jpids/piad005
pmc: PMC10112675
doi:
Substances chimiques
BNT162 Vaccine
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
177-179Subventions
Organisme : Pfizer
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society.
Références
MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):422-428
pubmed: 35298453
Perm J. 2012 Summer;16(3):37-41
pubmed: 23012597
N Engl J Med. 2022 Aug 11;387(6):525-532
pubmed: 35857701
JAMA Netw Open. 2022 Dec 1;5(12):e2246915
pubmed: 36515946
Lancet Respir Med. 2022 Jul;10(7):689-699
pubmed: 35468336
Lancet Infect Dis. 2022 May;22(5):581-583
pubmed: 35325619
N Engl J Med. 2022 Oct 6;387(14):1332-1333
pubmed: 36103455
MMWR Morb Mortal Wkly Rep. 2022 Mar 04;71(9):352-358
pubmed: 35239634
Lancet. 2022 Jul 9;400(10346):97-103
pubmed: 35780801
N Engl J Med. 2022 Jul 21;387(3):227-236
pubmed: 35767475
Lancet. 2021 Oct 16;398(10309):1407-1416
pubmed: 34619098
N Engl J Med. 2022 May 19;386(20):1899-1909
pubmed: 35353976
Lancet Reg Health Am. 2022 Apr;8:100246
pubmed: 35399648
JAMA. 2022 Jan 4;327(1):23-25
pubmed: 34910088
MMWR Morb Mortal Wkly Rep. 2021 Nov 12;70(45):1579-1583
pubmed: 34758012
Am J Epidemiol. 2021 May 4;190(5):918-927
pubmed: 33124649
Lancet Reg Health Am. 2022 May;9:100198
pubmed: 35187521